MUMBAI (Reuters) - Cipla Ltd , India's fifth-largest drugmaker by sales, on Wednesday reported a 35 percent fall in quarterly profit, missing analysts' estimates.
Net profit in the July-September quarter was 3.54 billion rupees ($53.28 million), down from 5.43 billion rupees during the same period a year earlier. That compared with the average estimate of 3.92 billion rupees polled by analysts in a Thomson Reuters I/B/E/S poll.
(Reporting by Zeba Siddiqui; Editing by Biju Dwarakanath)
Disclaimer: No Business Standard Journalist was involved in creation of this content